The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Importance of performance status, corrected calcium, and microvascular invasion in predicting overall survival in patients with metastatic renal cell carcinoma at the era of molecular targeted therapy.
Masatoshi Eto
Honoraria - Otsuka
Tomomi Kamba
No relevant relationships to disclose
Hideaki Miyake
No relevant relationships to disclose
Masato Fujisawa
No relevant relationships to disclose
Takao Kamai
Honoraria - Otsuka
Hirotsugu Uemura
No relevant relationships to disclose
Taiji Tsukamoto
No relevant relationships to disclose
Haruhito Azuma
No relevant relationships to disclose
Akio Matsubara
No relevant relationships to disclose
Kazuo Nishimura
Honoraria - Otsuka
Tsuyoshi Nakamura
No relevant relationships to disclose
Osamu Ogawa
No relevant relationships to disclose
Seiji Naito
Honoraria - Otsuka